CTSZ

Cathepsin Z · Q9UBR2 · CTSZ on Sugi Atlas →

420 patent compounds predicted against CTSZ, 263 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL22639759 SCHEMBL22639759 0.61 5/20
SCHEMBL14408085 SCHEMBL14408085 0.56 4/20
SCHEMBL5375177 SCHEMBL5375177 0.55 4/20
SCHEMBL4930035 SCHEMBL4930035 0.47 4/20
SCHEMBL3346407 SCHEMBL3346407 1.00 3/20
SCHEMBL3353019 SCHEMBL3353019 1.00 3/20
SCHEMBL8015461 SCHEMBL8015461 0.40 3/20
SCHEMBL3347831 SCHEMBL3347831 1.00 2/20
SCHEMBL3350907 SCHEMBL3350907 1.00 2/20
SCHEMBL3346441 SCHEMBL3346441 0.75 2/20
SCHEMBL3348177 SCHEMBL3348177 0.75 2/20
SCHEMBL3380592 SCHEMBL3380592 0.71 2/20
SCHEMBL13363712 SCHEMBL13363712 0.71 2/20
SCHEMBL3347915 SCHEMBL3347915 0.70 2/20
SCHEMBL3346602 SCHEMBL3346602 0.70 2/20
SCHEMBL4838855 SCHEMBL4838855 0.69 2/20
SCHEMBL3346331 SCHEMBL3346331 0.68 2/20
SCHEMBL27303713 SCHEMBL27303713 0.61 2/20
SCHEMBL5031260 SCHEMBL5031260 0.58 2/20
SCHEMBL14408074 SCHEMBL14408074 0.55 2/20

Clinical trials — most relevant to CTSZ by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Efficacy and Safety of Favipiravir and Ribavirin Formulation for Treatment of COVID-19 PHASE2/PHASE3UNKNOWN
DEFINE - Evaluating Therapies for COVID-19 PHASE1/PHASE2COMPLETED
Sputum Matrix Metalloproteinases (MMP) mRNA and Montelukast PHASE2COMPLETED
Comparative Clinical Study to Evaluate the Possible Efficacy and Safety of Oral N-Acetyl Cysteine Versus Rectal Diclofenac in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis PHASE1/PHASE2COMPLETED
The Study of Quadruple Therapy Quercetin, Zinc, Metformin, and EGCG as Adjuvant Therapy for Early, Metastatic Breast Cancer and Triple-negative Breast Cancer, a Novel Mechanism EARLY_PHASE1UNKNOWN
Detection of Cancer-Specific Active Proteases in Blood Via Fluorescence nanWITHDRAWN
Respiratory Cathepsins, Proteases Inhibitors and Glycosaminoglycans (GAG) in Mucopolysaccharidosis nanCOMPLETED
Turkish Adaptation of the CTS-6 Evaluation Tool: A Validation and Reliability Study nanNOT_YET_RECRUITING
Rab 32 Gene Polymorphisms as a Prognostic Factor in Leprosy Patients nanRECRUITING
Synovial Fluid Bank From Arthritic Patients nanRECRUITING
Diagnostic Value of Serum Cathepsin S and Chromogranin A in DKD nanNOT_YET_RECRUITING
Multimodal Approach of Electrotherapy Versus Nerve Flossing Technique in Patient With Carpal Tunnel Syndrome nanUNKNOWN
Predicting Pancreatic Necrosis Using mitDNA nanUNKNOWN
Hematological Markers in Idiopathic Carpal Tunnel Syndrome nanCOMPLETED
The Role of Vitamin K2 in Preventing Glucocorticoid-Induced Bone Loss in Children With Nephrotic Syndrome nanRECRUITING
Fasting, Exercise, and Diet to Activate Autophagy in Depression nanNOT_YET_RECRUITING
SRT in Comparison to ERT on Immune Aspects and Bone Involvement in Gaucher Disease nanUNKNOWN
Screening of Lysosomal Storage Disorders Diseases in Minority Groups nanUNKNOWN
Association Between Matrix Metalloproteinase-2 Gene Polymorphism rs243865 and Susceptibility to Cataract Development nanCOMPLETED
Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical Study nanRECRUITING
Correlation Between Serum Markers of Unstable Plaque and Virtual Histology of Unstable Plaque Visualized by IVUS nanCOMPLETED
Effect of Exercise on Ultrasound SWV in CTS Patients nanCOMPLETED
Bace1as Role in Heart Failure (BACE1AS-HF) nanCOMPLETED
Utility of Presepsin in Children Sepsis nanUNKNOWN
Molecular Content of Peri-implant Sulcus During Wound Healing and Osseointegration Following Drilling and Piezosurgery nanCOMPLETED
Salivary Markers in Periodontal Disorders nanCOMPLETED
Chemokine Mechanisms in Chronic Pelvic Pain nanCOMPLETED
Comparison of Clinical Efficacy of Submucosal Dexamethasone and Oral Trypsin-chymotrypsin for Reduction of Postoperative Sequelae After Lower Third Molar Surgery nanRECRUITING
Apoptosis Markers in Aggressive Periodontitis nanCOMPLETED
Influence of Statins in Artery Aneurysms nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a CTSZ binder may also engage these)

ProteinNameSimilarity
P05689 1.000 P05689 →
Q9WUU7 1.000 Q9WUU7 →
Q9R1T3 0.998 Q9R1T3 →
G5EGP8 0.995 G5EGP8 →
P83205 0.990 P83205 →
Q6PN98 0.989 Q6PN98 →
P25802 0.989 P25802 →
P07688 0.987 P07688 →
P90850 0.987 P90850 →
A1E295 0.987 A1E295 →
P19092 0.986 P19092 →
P43233 0.986 P43233 →
Q5R6D1 0.986 Q5R6D1 →
P25793 0.985 P25793 →
Q9SUL1 0.985 Q9SUL1 →
CTSB Cathepsin B 0.984 landscape →
Q4R5M2 0.984 Q4R5M2 →
Q9UJW2 0.984 Q9UJW2 →
P00787 0.983 P00787 →
Q9TST1 0.983 Q9TST1 →
Q9R013 0.982 Q9R013 →
CTSC Dipeptidyl peptidase 1 0.982 landscape →
P35591 0.981 P35591 →
P25775 0.981 P25775 →
P92132 0.981 P92132 →
P10605 0.981 P10605 →
P92133 0.980 P92133 →
P25250 0.980 P25250 →
P43509 0.980 P43509 →
P43296 0.980 P43296 →